Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cend Therapeutics

http://drugcendr.com

Latest From Cend Therapeutics

Oncology Accelerates In China As Large Makers Hunt For Assets

New regulatory measures shorten clinical trial approval times and usher in busy deal-making between large makers and smaller biotechs outside China.

China Cancer

Asia Deal Watch: Genexine Teams With KGBio In Immuno-Oncology, COVID-19 Therapy

Plus deals involving Scynexis/Hansoh, Cend/Qilu, Apollomics/Edison, Apollomics/Iterion, Apollomics/Nuance, Aerami/Chance, Antibe/Nuance, Ildong/Arbormed

Deals Business Strategies

Deal Watch: Private Equity-Backed Covis Bids To Buy Troubled AMAG

Following a strategic review, AMAG goes to Covis. Vincera goes public in merger with blank check company, has pending cancer deal with Bayer.

Deals Business Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
  • Other Names / Subsidiaries
    • DrugCendR Inc
    • Impilo Therapeutics, Inc.
UsernamePublicRestriction

Register